Reference
Rodriguez de Vera GomezP, et al. Alemtuzumab induces severe orbitopathy in relapsing-remitting multiple sclerosis. Journal of Neurology 271 : 486-496, Sep 2023. Available from: URL: https://dx.doi.org/10.1007/s00415-023-11995-6
Rights and permissions
About this article
Cite this article
Alemtuzumab. Reactions Weekly 2002, 28 (2024). https://doi.org/10.1007/s40278-024-55405-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-024-55405-3